Meeting your high standards for manufacturing animal health pharmaceuticals
As the world's only global animal health CRO/CDMO, Argenta is trusted by customers to provide scalable manufacturing capabilities to deliver world-class treatments and therapies for healthier and happier animals.
The pursuit of meeting quality manufacturing standards, on any scale
Developers of animal health products have to factor in multiple variables when sourcing manufacturing solutions. They need to maintain regulatory compliance and ensure scalability, while also enabling product innovation.
Regulatory compliance and quality assurance
Meeting the requirements of regulatory agencies such as the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) demands strict adherence to Good Manufacturing Practices, including consistent production processes and robust quality control.
Scalability and production efficiency
Achieving scalability in veterinary medicine manufacturing can pose challenges, especially when transitioning from R&D to commercial production. Balancing increased volumes while ensuring consistent quality requires agile technologies that can effectively scale.
Expertise in modern manufacturing methods
The veterinary pharmaceuticals market is continually evolving. To stay competitive, animal health drug developers need access to state-of-the-art manufacturing technologies that can help optimise processes, maintain product consistency, and meet emerging consumer needs.
Finding a partner that will prioritise your product
Animal health products are produced in a much lower volume than human health products. Therefore, many CDMOs and CMOs will prioritise human health product manufacture. Finding a partner that champions the manufacture of animal health products is critical to avoid slipping timelines.
Deep expertise: Exclusive manufacture of animal health products
Exceptional manufacturing expertise
As the world’s only CRO/CDMO dedicated to animal health products, our global teams have extensive expertise in animal drug manufacturing, offering advice and capabilities around delivery systems, formulation, and packaging. Working closely with you, our strategic guidance can enhance the manufacturing process for your animal health products.
State-of-the-art manufacturing
Our three global manufacturing sites are EMA- and FDA-approved, as well as GMP-compliant. We currently produce over 75 different commercial animal health products across these sites and are continuously innovating to develop new product types, formulations, and manufacturing processes.
Success at any scale
Our size, flexibility, and expertise enable us to scale manufacturing for our customers' animal health products, empowering them to focus instead on creating awareness, demand, and growth for their new solutions via marketing and distribution.
At Argenta, we have a long track record of success, so you can rest assured you’re in good hands:
1 billion+
doses of animal health pharmaceuticals produced annually
75+
commercial products manufactured yearly
375+
different stock-keeping-units (SKUs)
20+
technology transfers of commercial products in 5 years
3
EMA and FDA GMP-approved facilities on three continents
Related solutions
From ‘molecule to market’, Argenta offers a comprehensive package of services to support your commercialisation goals. Wherever you are in your product development journey, we can help.